Trials that use: Multiplicity adjustment
New to this method? Read the tutorial →
20,317 results
- PINTIndependent statistical analysis of The Effect of Raltegravir on HIV Decay During Primary and Chronic Infection: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- PIO-EXIndependent statistical analysis of Effect of Pioglitazone and Exenatide on Body Weight and Beta Cell Function: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- PIO-TACEIndependent statistical analysis of Effect of Pioglitazone on TIMP-3 and TACE in Type 2 Diabetes: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- PIOGASIndependent statistical analysis of Pioglitazone for Idiopathic Gastroparesis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04300127).
- Pioglitazone as a Treatment for Lipid and Glucose Abnormalities In Patients With Schizophrenia: Complete Statistical AnalysisIndependent statistical analysis of Pioglitazone as a Treatment for Lipid and Glucose Abnormalities In Patients With Schizophrenia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Pioglitazone Before Peginterferon and Ribavirin for Hepatitis C Infection in HIV/HCV-Coinfected Patients With Insulin Resistance: Complete Statistical AnalysisIndependent statistical analysis of Pioglitazone Before Peginterferon and Ribavirin for Hepatitis C Infection in HIV/HCV-Coinfected Patients With Insulin Resistance: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Pioglitazone for the Treatment of Bipolar Depression: Complete Statistical AnalysisIndependent statistical analysis of Pioglitazone for the Treatment of Bipolar Depression: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01717040).
- Pioglitazone Special Drug Use Surveillance “Metabolic Syndrome in Patients With Type 2 Diabetes Mellitus”: Complete Statistical AnalysisIndependent statistical analysis of Pioglitazone Special Drug Use Surveillance "Metabolic Syndrome in Patients With Type 2 Diabetes Mellitus": primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Pioglitazone Tablets Special Drug Use Surveillance “Combined Use of Biguanides / Long-term Treatment”: Complete Statistical AnalysisIndependent statistical analysis of Pioglitazone Tablets Special Drug Use Surveillance "Combined Use of Biguanides / Long-term Treatment": primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Pioglitazone to Treat Fatty Liver in People With HIV Infection: Complete Statistical AnalysisIndependent statistical analysis of Pioglitazone to Treat Fatty Liver in People With HIV Infection: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00441272).
- Pioglitazone Treatment for Hyperglycemic Acute Ischemic Stroke: Complete Statistical AnalysisIndependent statistical analysis of Pioglitazone Treatment for Hyperglycemic Acute Ischemic Stroke: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04123067).
- Pioglitazone vs Placebo in Combination With Niacin Extended Release on Low HDL: Complete Statistical AnalysisIndependent statistical analysis of Pioglitazone vs Placebo in Combination With Niacin Extended Release on Low HDL: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Pioglitazone/Glimepiride (Sonias) Combination Tablets Special Drug Use Surveillance Survey in Patients With Type 2 Diabetes Mellitus Who Respond Poorly to Pioglitazone: Complete Statistical AnalysisIndependent statistical analysis of Pioglitazone/Glimepiride (Sonias) Combination Tablets Special Drug Use Surveillance Survey in Patients With Type 2 Diabetes Mellitus Who Respond Poorly to Pioglitazone: primary endpoint results, effect estimate with confidence…
- PIONEERIndependent statistical analysis of The Effect of Atorvastatin and Pioglitazone on Carotid Atherosclerosis With the Use of Positron Emission Tomography-computed Tomography (PET-CT): primary endpoint results, effect estimate with confidence interval, sample-size planning…
- PIONEER 1Independent statistical analysis of Efficacy and Safety of Oral Semaglutide Versus Placebo in Subjects With Type 2 Diabetes Mellitus Treated With Diet and Exercise Only: primary endpoint results, effect estimate with confidence…
- PIONEER 10Independent statistical analysis of Safety and Efficacy of Oral Semaglutide Versus Dulaglutide Both in Combination With One OAD (Oral Antidiabetic Drug) in Japanese Subjects With Type 2 Diabetes: primary endpoint results, effect…
- PIONEER 4Independent statistical analysis of Efficacy and Safety of Oral Semaglutide Versus Liraglutide and Versus Placebo in Subjects With Type 2 Diabetes Mellitus: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- PIONEER AF-PCIIndependent statistical analysis of A Study Exploring Two Strategies of Rivaroxaban (JNJ39039039; BAY-59-7939) and One of Oral Vitamin K Antagonist in Patients With Atrial Fibrillation Who Undergo Percutaneous Coronary Intervention: primary endpoint…
- PIONEER IIndependent statistical analysis of Efficacy and Safety Study of Adalimumab in Treatment of Hidradenitis Suppurativa: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- PIONEER III Trial to Assess Safety and Efficacy of the BuMA Supreme™ Drug Coated Coronary Stent in Patients With Coronary Disease: Complete Statistical AnalysisIndependent statistical analysis of PIONEER III Trial to Assess Safety and Efficacy of the BuMA Supreme™ Drug Coated Coronary Stent in Patients With Coronary Disease: primary endpoint results, effect estimate with confidence…
- PIONEER TEENSIndependent statistical analysis of A Research Study to Compare a New Medicine Oral Semaglutide to a Dummy Medicine in Children and Teenagers With Type 2 Diabetes: primary endpoint results, effect estimate with…
- PIONEER-HFIndependent statistical analysis of Comparison of Sacubitril/Valsartan Versus Enalapril on Effect on NT-proBNP in Patients Stabilized From an Acute Heart Failure Episode.: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- PIOPKDIndependent statistical analysis of Use of Low Dose Pioglitazone to Treat Autosomal Dominant Polycystic Kidney Disease: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- PIPAC-nabpacIndependent statistical analysis of PIPAC Nab-pac for Stomach, Pancreas, Breast and Ovarian Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03304210).
- PIPE-CFIndependent statistical analysis of Continuous Infusion Piperacillin-tazobactam for the Treatment of Cystic Fibrosis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01694069).
- Pippa Pessary Study (Clinical Trial): Complete Statistical AnalysisIndependent statistical analysis of Pippa Pessary Study (Clinical Trial): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05611970).
- Piroxicam and Levonorgestrel Co-treatment for Emergency Contraception: Complete Statistical AnalysisIndependent statistical analysis of Piroxicam and Levonorgestrel Co-treatment for Emergency Contraception: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03614494).
- PISCESIndependent statistical analysis of Patient Preference Study of Pazopanib Versus Sunitinib in Advanced or Metastatic Kidney Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- PITCH-EIndependent statistical analysis of Pain Inflammation and Cannabis in HIV: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05554146).
- PIVoTALIndependent statistical analysis of Comparison of Pulmonary Vein Ablation With or Without Left Atrial Posterior Wall Ablation for Persistent AF (PIVoTAL): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- PivotalIndependent statistical analysis of MarginProbe, a Device for Intraoperative Assessment of Margin Status in Breast Conservation Surgery: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Pivotal Bioequivalence Study to Qualify Manufacturing Site Transfer for Prazosin Hydrochloride Capsules: Complete Statistical AnalysisIndependent statistical analysis of Pivotal Bioequivalence Study to Qualify Manufacturing Site Transfer for Prazosin Hydrochloride Capsules: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Pivotal Study (Pharmacokinetics, Efficacy, Safety) of BAX 326 (rFIX) in Hemophilia B Patients: Complete Statistical AnalysisIndependent statistical analysis of Pivotal Study (Pharmacokinetics, Efficacy, Safety) of BAX 326 (rFIX) in Hemophilia B Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Pivotal Study in Advanced Parkinsons Disease Patients: Complete Statistical AnalysisIndependent statistical analysis of Pivotal Study in Advanced Parkinsons Disease Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00466167).
- Pivotal Study of Iodine I 131 Tositumomab for Chemotherapy-refractory Low-grade or Transformed Low-grade B-cell Non-Hodgkin’s Lymphoma: Complete Statistical AnalysisIndependent statistical analysis of Pivotal Study of Iodine I 131 Tositumomab for Chemotherapy-refractory Low-grade or Transformed Low-grade B-cell Non-Hodgkin's Lymphoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Pivotal Study of the truSculpt Radiofrequency Device for Circumferential Reduction: Complete Statistical AnalysisIndependent statistical analysis of Pivotal Study of the truSculpt Radiofrequency Device for Circumferential Reduction: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02873104).
- Pivotal, Multicenter, Observer-Blind, Randomized Study of Influenza A (H1N1)2009 Monovalent Subunit Vaccine With and Without Adjuvant in Children Ages 6 to <36 Months: Complete Statistical AnalysisIndependent statistical analysis of Pivotal, Multicenter, Observer-Blind, Randomized Study of Influenza A (H1N1)2009 Monovalent Subunit Vaccine With and Without Adjuvant in Children Ages 6 to
- PIX-RIndependent statistical analysis of Comparison of Pixantrone + Rituximab With Gemcitabine + Rituximab in Patients With Aggressive B-cell Non-Hodgkin Lymphoma or Follicular Grade 3 Lymphoma Who Have Relapsed After Therapy and Are…
- PizzaIndependent statistical analysis of A Short-Term Appetite Suppression Trial Using Appethyl™: The Pizza: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01919814).
- PJSPhDIndependent statistical analysis of Chesterfield Micro-implant Study Involving Three Types of Anchorage Methods in Orthodontics: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- PKIndependent statistical analysis of A Study to Assess the Pharmacokinetics and Safety of Different Forms and Formulations of AZD9496 in Healthy Subjects: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- PK and ECG Determinations Following 8 Weeks of HyBryte Treatment for Cutaneous T-Cell Lymphoma: Complete Statistical AnalysisIndependent statistical analysis of PK and ECG Determinations Following 8 Weeks of HyBryte Treatment for Cutaneous T-Cell Lymphoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- PK and Safety of Remdesivir for Treatment of COVID-19 in Pregnant and Non-Pregnant Women in the US: Complete Statistical AnalysisIndependent statistical analysis of PK and Safety of Remdesivir for Treatment of COVID-19 in Pregnant and Non-Pregnant Women in the US: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- PK Profile and Preliminary Efficacy of TNP-2092 Capsules in Liver Cirrhosis Patients With Hyperammonemia: Complete Statistical AnalysisIndependent statistical analysis of PK Profile and Preliminary Efficacy of TNP-2092 Capsules in Liver Cirrhosis Patients With Hyperammonemia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- PK/ADAIndependent statistical analysis of Evaluate the Pharmacokinetics, Safety, and Tolerability of Nirsevimab in Healthy Chinese Adults: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- PKRIndependent statistical analysis of Triathlon® Partial Knee Replacement (PKR) Outcomes Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00966979).
- PKUIndependent statistical analysis of Fluorodeoxyglucose Positron Emission Tomography (FDG PET) Findings in Patients With Phenylketonuria Before and After KUVAN Therapy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- PKU-015Independent statistical analysis of Effect of Kuvan on Neurocognitive Function, Blood Phenylalanine Level, Safety, and Pharmacokinetics in Children With PKU: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- PlaceboIndependent statistical analysis of Efficacy of Open Label Placebo in Children With FGIDs: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02389998).
- Placebo Controled Clinical Trial Using Topiramate To Treat Posttraumatic Stress Disorder (PTSD) Patients.: Complete Statistical AnalysisIndependent statistical analysis of Placebo Controled Clinical Trial Using Topiramate To Treat Posttraumatic Stress Disorder (PTSD) Patients.: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…